[ad_1]
6 September 2022
As part of its ongoing commitment
to transparency, Te Pātaka Whaioranga – Pharmac has today
shared their interim
response to the Pharmac Review. It includes initial
steps it has taken, as well as future projects and
initiatives it intends to carry out.
“We’re
grateful for the opportunity to reflect on what we do, and
how we do it,” says Pharmac’s Chief Executive Sarah
Fitt. “We have welcomed the review’s findings and agree
with the key areas for our improvement.
“Since 1993,
Pharmac has worked hard to ensure funded medicines and
medical devices are accessible for people in New Zealand.
Alongside the recommendations and commentary, it was
reassuring to hear the committee’s recognition of the
important role Pharmac plays, and their view that the
overall model is sound and continues to deliver significant
benefits for New Zealand.
“We recognise, however,
that we can improve the way Pharmac makes decisions around
funding medicines and medical devices. We believe there are
four key areas which we need to focus on making these
changes. These are:
- Enhanced assessment and
decision-making - Te Tiriti excellence
- Doing
more to achieve health equity - Better involvement of
and collaboration with others
“In developing
our interim response, we sought input from the Ministry of
Health, Te Whatu Ora and Te Aka Whai Ora, to help ensure a
more integrated health system. We also sought input from our
advisory committees – Pharmacology and Therapeutics
Advisory Committee and Consumer Advisory Committee – to
ensure clinical and consumer perspectives were factored into
our response.
Pharmac’s full response to the review
is due with the Minister of Health at the end of October.
This will focus on a longer-term work programme.
“We
will share the full response and provide regular updates on
our progress so the public can be assured in our efforts and
intentions to do better overall, for all people in New
Zealand.”
© Scoop Media
[ad_2]
Source link